- AliveCor — a leader in AI-based personal ECG technology and provider of enterprise cardiology solutions — announced it has raised $65 million in Series E funding
AliveCor — a leader in AI-based personal ECG technology and provider of enterprise cardiology solutions — announced it has raised $65 million in Series E funding led by existing investors OMRON, Khosla Ventures, WP Global Partners, Qualcomm Ventures, and Bold Capital Partners. The proceeds from the funding will be used to accelerate growth of AliveCor’s remote cardiology platform both domestically and around the world.
The company’s AI-powered ECG determinations will be augmented with telehealth services as well as with detection and condition management services for providers and institutions. And the enhanced partnership with OMRON will also position the company to include hypertension management within its service portfolio.
So far, AliveCor products have served over one million customers around the world and recorded more than 85 million ECGs. This data set gives the company a meaningful advantage in building new AI-based services to drive a new age of advanced and improved cardiological care. And AliveCor believes that comprehensive services coupled with AI-powered diagnostics will have an ongoing impact on cost, quality, and on responsiveness — resolving false positives and improving the response time in medical emergencies.
“We are grateful for the continued confidence of our investors. This financing speaks to the transformative power our technology brings to the healthcare system. We remain positioned to fulfill our vision of delivering AI-based, remote cardiological services for the vast majority of cases when cardiac patients are not in front of their doctor.”
— Priya Abani, CEO of AliveCor